Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy



Status:Completed
Conditions:Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:19 - Any
Updated:3/15/2019
Start Date:April 30, 2014
End Date:January 24, 2019

Use our guide to learn which trials are right for you!

A Prospective, Single-Blinded, Randomized Study of Awake vs Intubated General Anesthesia in Patients Undergoing Elective Craniotomy for Supratentorial Glioma Resection

This randomized clinical trial studies light sedation compared with intubated general
anesthesia (a loss of feeling and a complete loss of awareness that feels like a very deep
sleep) in reducing complications and length of hospital stay in patients with brain cancer
undergoing craniotomy. Craniotomy is an operation in which a piece of the skull is removed so
doctors can remove a brain tumor or abnormal brain tissue. Light sedation allows patients to
remain awake during their surgery, while intubated general anesthesia puts patients to sleep.
Surgery complication rates may be reduced if intubated general anesthesia is avoided.
Additionally, patients not receiving intubated general anesthesia tend to recover more
quickly after surgery. It is not yet known whether light sedation is better at reducing
complications and length of hospital stay compared to intubated general anesthesia.

PRIMARY OBJECTIVES:

I. To compare the overall hospital length of stay (LOS) in patients undergoing craniotomy
with light sedation vs. general anesthesia.

SECONDARY OBJECTIVES:

I. To compare resource utilization between the two groups. II. To assess the frequency of
post-operative delirium. III. To measure patient perceptions. IV. To track patient
complications during hospital stay - nausea/vomiting, pain, hematology/lab stability,
hemodynamic stability.

V. To track re-admission and extended hospital stay rates. VI. To compare cost of both
approaches.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive light sedation (awake) and undergo craniotomy.

ARM II: Patients receive intubated general anesthesia and undergo craniotomy.

After completion of study, patients are followed up at 1month and 1 year.

Inclusion Criteria:

- Non-pregnant females

- Elective craniotomy for supratentorial brain tumors

- Primary brain cancer (presumed gliomas with no radiographic or clinical evidence of
metastatic disease to the brain)

- First craniotomy

- American Society of Anesthesiologists (ASA) I-III

- Body mass index (BMI) < 35

Exclusion Criteria:

- Posterior fossa tumor/approach for tumor resection requiring the prone position

- Traumatic lesions/hematomas

- Emergency case

- Systemic disease burden with metastatic tumor to the brain

- Presence of medical co-morbidities, which, in the opinion of the investigator
complicates the surgical procedure or would require additional hospital stay

- Necessity of awake procedure requiring intraoperative participation of patient due to
the presence of the lesion in eloquent brain areas

- Prisoners

- Pregnant women
We found this trial at
1
site
300 W 10th Ave
Columbus, Ohio 43210
(800) 293-5066
Principal Investigator: James Elder
Phone: 614-366-8327
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center...
?
mi
from
Columbus, OH
Click here to add this to my saved trials